Diabetes Mellitus, Type 1

Showing NaN - NaN of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 1 Trial in United States (insulin lispro, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin lispro
  • insulin aspart
  • Mobile, Alabama
  • +51 more
Dec 21, 2016

Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin human
  • +2 more
  • Birmingham, Alabama
  • +75 more
Dec 21, 2016

Diabetes, Type 1 Trial in Canada, United States (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +52 more
Jun 7, 2016

Diabetes, Type 1 Trial in United States (pramlintide acetate)

Completed
  • Diabetes Mellitus, Type 1
  • pramlintide acetate
  • Tempe, Arizona
  • +24 more
Sep 22, 2015

Diabetes, Type 1 Trial in United States (Aralast NP, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 1
  • Aralast NP
  • Placebo
  • La Jolla, California
  • +14 more
Dec 30, 2014

Diabetes, Type 1 Trial in Worldwide (LY2963016, Lantus, Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 1
  • Birmingham, Alabama
  • +51 more
Oct 3, 2014

Diabetes, Type 1 Trial in San Antonio (Allogeneic Cultured Islet Cells (human); Encapsulated)

Terminated
  • Diabetes Mellitus, Type 1
  • Allogeneic Cultured Islet Cells (human); Encapsulated
  • San Antonio, Texas
  • +1 more
Sep 8, 2014

Diabetes, Type 1, Diabetes, Type 2 Trial in United States (4 mm x 32G Pen Needle, 8mm x 31G Pen Needle, 12.7mm x 29G Pen Needle)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • 4 mm x 32G Pen Needle
  • +2 more
  • Escondido, California
  • +9 more
May 27, 2014

Diabetes, Type 1, Diabetes, Type 2, Diabetic Polyneuropathy Trial in Mexico, United States (SB-509, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • +2 more
  • SB-509
  • Placebo
  • La Jolla, California
  • +19 more
Oct 30, 2012

Diabetes, Type 1, Diabetes, Type 2, Diabetic Polyneuropathy Trial in United States (SB-509, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • +2 more
  • La Jolla,, California
  • +3 more
Oct 30, 2012

Diabetes, Type 1, Diabetes, Type 2, Diabetic Polyneuropathy Trial in Mexico, United States (SB-509, Normal Saline)

Completed
  • Diabetes Mellitus, Type 1
  • +2 more
  • La Jolla, California
  • +14 more
Oct 30, 2012

Diabetes, Type 1, Diabetes, Type 2, Asthma Trial in Worldwide (Technosphere Insulin)

Terminated
  • Diabetes Mellitus, Type 1
  • +2 more
  • Technosphere Insulin
  • Phoenix, Arizona
  • +77 more
May 3, 2012

Diabetes, Type 1 Trial in Worldwide (Insulin Lispro Protamine Suspension, Insulin Levemir)

Completed
  • Diabetes Mellitus, Type 1
  • Insulin Lispro Protamine Suspension
  • Insulin Levemir
  • Idaho Falls, Idaho
  • +27 more
Oct 20, 2010

Diabetes, Type 1 Trial in Worldwide (Subcutaneous Insulin, Inhaled Insulin)

Terminated
  • Diabetes Mellitus, Type 1
  • Subcutaneous Insulin
  • Inhaled Insulin
  • Fullerton, California
  • +72 more
Feb 3, 2010

Diabetes, Type 1 Trial in Glendale, Fresno, San Antonio (Inhaled insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Inhaled insulin
  • Glendale, Arizona
  • +2 more
Mar 9, 2008

Diabetes, Type 1 Trial in United States (insulin, human insulin inhalation powder (HIIP))

Completed
  • Diabetes Mellitus, Type 1
  • insulin
  • human insulin inhalation powder (HIIP)
  • San Diego, California
  • +24 more
Dec 20, 2007

Diabetes, Type 1 Trial in Canada, United States (Inhaled human insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Inhaled human insulin
  • Burlingame, California
  • +36 more
Feb 9, 2007

Diabetes, Type 1, Diabetes, Type 2 Trial in United States (INGAP Peptide)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • INGAP Peptide
  • San Diego, California
  • +3 more
Jun 23, 2005